--- title: "Pre-market hot trades in US stocks: PicoCELA pre-market down 10.72%; Curanex Pharmaceuticals pre-market down 10.44%" type: "News" locale: "en" url: "https://longbridge.com/en/news/296592894.md" description: "PicoCELA pre-market down 10.72%; Curanex Pharmaceuticals pre-market down 10.44%; RF Acquisition Corp II pre-market up 371.33%; RF ACQUISITION CORP II COM USD0.0001(S/R 15/02/2027) pre-market up 95.45%; Addex Therapeutics pre-market up 87.10%" datetime: "2026-08-21T09:02:14.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296592894.md) - [en](https://longbridge.com/en/news/296592894.md) - [zh-HK](https://longbridge.com/zh-HK/news/296592894.md) generator: "portal-rs" --- # Pre-market hot trades in US stocks: PicoCELA pre-market down 10.72%; Curanex Pharmaceuticals pre-market down 10.44% **Popular Pre-Market Trades in U.S. Stocks** PicoCELA is down 10.72% in pre-market trading. Based on recent news, 1. On August 18, Fort Technology acquired a majority stake in Logia USA, strengthening the data center fuel maintenance market. This move raised concerns about PicoCELA, leading to a drop in its stock price. 2. On August 18, Eastman Kodak reported an 18% increase in second-quarter revenue and a 61% surge in gross profit. The company demonstrated the strategic value of traditional manufacturing by restarting large-format analog film and developing a new generation of PFAS-free batteries, impacting market confidence in PicoCELA. 3. On August 18, the market's emphasis on supply chain resilience outweighed pure software profits, leading to a reassessment of uncategorized industrial stocks (such as CBRGF.US). This trend negatively affected PicoCELA's stock price, with increased market focus on supply chain resilience and traditional manufacturing. Curanex Pharmaceuticals is down 10.44% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation. **Top Gainers in U.S. Pre-Market Trading** RF Acquisition Corp II is up 371.33% in pre-market trading. Based on recent key news: 1. On August 20, RF Acquisition Corp II filed important documents through the EDGAR system, disclosing company information. This disclosure may have sparked positive market expectations for the company's future development, driving a significant increase in stock price. 2. On August 21, shareholders submitted a preliminary request to redeem 3.95 million shares of RFAC stock, although these requests may change before the transaction is completed. This news may lead to a reassessment of the company's liquidity and shareholder confidence, further impacting the stock price. 3. Recently, RF Acquisition Corp II's stock price approached its 52-week high, with a relative strength index (RSI) of 68.83, indicating strong market momentum. The performance of this technical indicator may have attracted more investor attention, driving the stock price up. Market momentum is strong, and investor interest is high. RF ACQUISITION CORP II COM USD0.0001 (S/R 15/02/2027) is up 95.45% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation. Addex Therapeutics is up 87.10% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation ### Related Stocks - [PCLA.US](https://longbridge.com/en/quote/PCLA.US.md) - [CURX.US](https://longbridge.com/en/quote/CURX.US.md) - [RFAI.US](https://longbridge.com/en/quote/RFAI.US.md) - [RFAIR.US](https://longbridge.com/en/quote/RFAIR.US.md) - [ADXN.US](https://longbridge.com/en/quote/ADXN.US.md) ## Related News & Research - [Curanex Pharmaceuticals Inc Q2 2026: Net income $(3.29M), EPS $(0.12) — 10-Q Summary](https://longbridge.com/en/news/295957896.md) - [Apimeds Pharmaceuticals US Enters Assignment And Transfer Agreement With Freet On August 19](https://longbridge.com/en/news/296655292.md) - [Rhythm Pharmaceuticals Eyes AHO Growth, Global IMCIVREE Expansion and Pipeline Catalysts](https://longbridge.com/en/news/296061716.md) - [Halozyme Appoints Dannielle Appelhans to its Board of Directors | HALO Stock News](https://longbridge.com/en/news/296264824.md) - [Mitsubishi UFJ Trust & Banking Corp Buys 54,637 Shares of ConocoPhillips $COP](https://longbridge.com/en/news/296084237.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**